SCHEMBL30104255

SCHEMBL30104255

COc1ccc(C(OC[C@]2(CO)O[C@@H](c3ccc4c(NC(=O)OC(C)(C)C)ncnn34)[C@@H]3OC(C)(C)O[C@@H]32)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30104265 0.93 — —
SCHEMBL16699605 0.93 SLC6A1 (0.30) —
SCHEMBL16699003 0.86 — —
SCHEMBL16710444 0.86 NPSR1 (0.32) —
SCHEMBL16710859 0.86 NPSR1 (0.32) —
SCHEMBL19778894 0.85 CYP3A4 (0.30) —
SCHEMBL23844102 0.84 NPSR1 (0.31) —
SCHEMBL16710445 0.84 NPSR1 (0.31) —
SCHEMBL16708538 0.84 NPSR1 (0.31) —
SCHEMBL19101733 0.83 NPSR1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4122932-A1 PYRROLO[1,2-F][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS Gilead Sciences, Inc. (US) 2023-01-25 — — EP disclosed
Send feedback